Reduced Early Mortality with Daratumumab-Based Frontline Therapy in Systemic AL Amyloidosis- Experience from the Columbia Amyloidosis Multidisciplinary Program

Chakraborty, R., Bhutani, D., Mapara, M., Reshef, R., Maurer, M. S., Radhakrishnan, J., & Lentzsch, S. (2023). Reduced Early Mortality with Daratumumab-Based Frontline Therapy in Systemic AL Amyloidosis- Experience from the Columbia Amyloidosis Multidisciplinary Program. Blood, 142(Supplement 1), 4780–4780. https://doi.org/10.1182/blood-2023-187214
Authors:
Rajshekhar Chakraborty
Divaya Bhutani
Markus Y. Mapara
Ran Reshef
Mathew S. Maurer
Jai Radhakrishnan
Suzanne Lentzsch
Affiliated Authors:
Rajshekhar Chakraborty
Divaya Bhutani
Markus Y. Mapara
Ran Reshef
Mathew S. Maurer
Jai Radhakrishnan
Suzanne Lentzsch
Columbia Affiliation:
Subjects:
Molecular Mechanisms of Amyloidosis (OpenAlex Topic)
Efficacy and Resistance in CML Treatment (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2023-187214
DOI:
10.1182/blood-2023-187214
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: